Steffen Lüders

Senior Vice President, Communication, Public Affairs and International Collaboration at @novonordiskfond and @novoholdings.

[Novo Nordisk Foundation @novonordiskfond]

International collaboration is the way forward if we are going to solve the biggest #health problems in the world today. As Mads Krogsgaard Thomsen explains in this video, that is why the NNF is moving towards more internationalisation in its efforts.
@broadinstitute

[Novo Nordisk Foundation @novonordiskfond]

NNF and the @broadinstitute of @MIT and @Harvard announced today the launch of a new Center for Genomic Mechanisms of Disease, an initiative that will accelerate efforts to mine genetic data for insights into disease mechanisms.
https://t.co/XXy3EZY7ZI

[Novo Nordisk Foundation @novonordiskfond]

Supported by a $47.5 million commitment from the Foundation, the Center will facilitate close collaborations between the @broadinstitute and Danish researchers investigating the #genetics and gene regulation of common complex disease.
https://t.co/gUoHuoDWUY

[Steffen Lüders @SteffenLuders]

Novo Nordisk Fonden og en række andre organisationer og virksomheder kritiserer i dag i @berlingske regeringens planer om at flytte forskningsbaserede uddannelser væk fra de store byer.
(Artikel bag betalingsmur)
#dkpol #uddpol
https://t.co/Fgu2GzhXzK

[Novo Nordisk Foundation @novonordiskfond]

CEO of the Novo Nordisk Foundation, Mads Krogsgaard Thomsen, is part of an Independent #Scientific Expert Group which have given recommendations to the #G7 for responding to the current #pandemic.
https://t.co/W4gFtRUkSb

[Novo Holdings @novoholdings]

Despite the huge societal costs of #antimicrobialresistance, there is no viable market for the development of new #antibiotics. Antibiotics that are in the early stages of development never reach patients because of a lack of funding for the later stages of clinical #research.

[Novo Holdings @novoholdings]

Novo Holdings posts record income and returns of DKK 29 billion (EUR 4 billion) in 2020.

[Novo Holdings @novoholdings]

Novo Holdings is pleased to note that it has participated in the $540 million Series F round in @noom, a leading digital health platform focused on behavior change.
#investorsinlifescience
https://t.co/XgWubWuEAW

[Novo Holdings @novoholdings]

Novo Holdings co-leads oversubscribed USD 110 M Series C in @Numab_Tx. Numab is a clinical stage #biopharmaceutical company developing next-generation multispecific antibody-based immunotherapies for cancer and inflammation.
#investorsinlifescience
https://t.co/VbDw0mTKJE

[Steffen Lüders @SteffenLuders]

Novo Nordisk Fondens støtte til almennyttige formål satte ny rekord i 2020.

[Novo Nordisk Foundation @novonordiskfond]

2020 was a busy year for the Novo Nordisk Foundation. The Foundation increased its total annual payouts for scientific, humanitarian and social purposes to DKK 4.6 billion (€620 million) and received a record number of grant applications.
https://t.co/1tEnGVDuL2

[Steffen Lüders @SteffenLuders]

På trods af Covid-19-krisen var 2020 et rekordår for Novo Holdings.
https://t.co/MkEzgWD9s1

[Steffen Lüders @SteffenLuders]

Vagtskifte i Novo Nordisk Fonden!
Det har været et privilegie at arbejde tæt sammen med Birgitte Nauntofte i de sidste mange år. Sikken en rejse fonden har været på. Nu ser jeg frem til de næste spændende kapitler med Mads Krogsgaard ved roret.
https://t.co/XaYMb8aXln

[Steffen Lüders @SteffenLuders]

Det er oplagt at bygge videre på verdens koordinerede indsats mod Covid-19 for at bekæmpe antibiotikaresistens. Det skriver Nordisk Fondens formand, Lars Rebien, i denne blog om antibiotikaresistens, som indledning til @Davos Agenda, som @wef står bag.
https://t.co/3cEFM7CliR

[Steffen Lüders @SteffenLuders]

Novo Nordisk Fonden har netop uddelt støtte til de første 12 projekter i fondens nye store satsning på datavidenskab og kunstig intelligens.
#grants #datascience #artificialintelligence
https://t.co/ytu1ywD4lV

[Steffen Lüders @SteffenLuders]

Hver dag dør ca. 2.000 mennesker pga. antibiotikaresistente infektioner. Samtidig bremser markedssituationen for, at vi får udviklet et tilstrækkeligt antal nye antibiotika.
#amr #AntimicrobialResistance
https://t.co/o60RXmWGCn

[Steffen Lüders @SteffenLuders]

Novo Seeds portfolio company Galecto prices IPO on Nasdaq. Galecto was first incubated by Novo Seeds and funded through the pre-seed grant programme of @novonordiskfond.
#novoholdings
https://t.co/jFz4cBaOiE

[Steffen Lüders @SteffenLuders]

Det er meget svært at studere bakterier i biofilm i laboratoriet og derved identificere de bedste muligheder for at slå dem ihjel. Det problem har danske forskere dog fundet en løsning på.
#amr #sciencenewsdk
https://t.co/TbOV0hKoBI

[Steffen Lüders @SteffenLuders]

Novo Ventures joins USD 110m crossover financing in VectivBio, a clinical-stage biotechnology company focused on developing transformational therapeutics for patients living with rare diseases.
#novoholdings
https://t.co/nGRwDZyLLR

[Steffen Lüders @SteffenLuders]

Novo Holdings today announced an investment in Rappta Therapeutics. Rappta’s PP2A-reactivating technologies offer the potential for a new class of anti-cancer drugs.
#novoholdings #investment #anticancer
https://t.co/iyLZq6Y8DG

[Steffen Lüders @SteffenLuders]

Har vi den rette balance mellem privat og offentlig finansiering af forskning?

https://t.co/z8CJg13kYR